Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.
about
Metabolomic profiling of ascending thoracic aortic aneurysms and dissections - Implications for pathophysiology and biomarker discoveryEfmoroctocog Alfa: A Review in Haemophilia A.Haemophilia patients' unmet needs and their expectations of the new extended half-life factor concentrates.Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden.Extended Half-Life Factor VIII and Factor IX Preparations.
P2860
Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Dosing regimens, FVIII levels ...... ith special focus on rFVIIIFc.
@en
type
label
Dosing regimens, FVIII levels ...... ith special focus on rFVIIIFc.
@en
prefLabel
Dosing regimens, FVIII levels ...... ith special focus on rFVIIIFc.
@en
P2093
P2860
P356
P1433
P1476
Dosing regimens, FVIII levels ...... with special focus on rFVIIIFc
@en
P2093
P2860
P304
P356
10.1111/HAE.12887
P50
P577
2016-02-11T00:00:00Z